News in a nutshell
- The number of orphan drug designations granted by the US Food and Drug Administration has risen sharply over the past 10 years, according to a new linkurl:study;http://csdd.beehivemedia.com/news/complete_story/pr_ir_nov_09 from the Tufts Center for the Study of Drug Development. There were 208 products designated as treatments for neglected diseases in 2000-2002; that number grew to 425 drugs or vaccines by 2006-2008. - A leading stem cell research advocate this weekend linkurl:called on;http
Written byBob Grant
From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
View Full Profile
Learn about our Editorial Policies.
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
**__Related stories:__***linkurl:Obama to lift stem cell ban;http://www.the-scientist.com/blog/display/55494/
[6th March 2009]*linkurl:The Orphan Drug Act Turns 25;http://www.the-scientist.com/article/display/55041/
[October 2008]*linkurl:First Person|Fotis Kafatos;http://www.the-scientist.com/article/display/14312/
[15th December 2003]
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Meet the Author
From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.
View Full Profile
Share
